Alzheimer's Disease Research Center

What Alzheimer's Disease Research Center does

The Alzheimer's Disease Research Center is a private, independent clinical research site in Albany, New York, founded in 1977 by Dr. Richard Holub. It conducts Phase I-IV clinical trials in Alzheimer's disease and related dementias, and over approximately four decades has run more than 134 trials with contributions cited across all five FDA-approved Alzheimer's medications. Patients receive diagnostic and clinical services at no cost; the site provides biomarker testing (including P-tau217 blood testing), APOE genetic testing under an NIH grant, PET imaging, and operates a 6,000+ sq ft facility with on-site lab, infusion suite, and exam rooms. Current operational scope includes roughly 10 active trials and 60 enrolled patients, drawn from the tri-state region (NY, VT, MA) and parts of Pennsylvania.

The business model is a hybrid sponsor-grant model. Trial-related revenue is generated from pharmaceutical sponsors — Eli Lilly, Eisai, Janssen, and Cassava are named — which pay per-patient fees and procedure reimbursements for protocol execution. A secondary revenue stream comes from NIH grant funding, exemplified by the APOE genetic testing program. Services are offered to patients free of charge, indicating that revenue is sourced entirely from sponsors and grants rather than direct patient billing. The center is a member site of the Global Alzheimer's Platform Foundation, providing visibility into sponsor pipelines.

Operationally the center runs with approximately 9-12 employees, including a small physician bench now comprising founder Dr. Richard Holub and Research Physician Dr. Robert Holub. There is no disclosed technology platform, software product, or digital infrastructure beyond clinical instruments and standard GCP-compliant data capture. The model is fundamentally a high-trust, principal-investigator-led site business, where differentiation rests on investigator reputation, longitudinal site experience, and protocol execution rather than technology assets.

Name

Alzheimer's Disease Research Center

Legal name

Alzheimer's Disease Research & Treatment Center Neurological Associates of Albany

Website

https://alzheimersresearchcenteralbany.com

Company type

Private

Founded year

1977

Operating status

Operating

Headcount range

1–10 employees

Short description

Independent clinical research site in Albany, NY, founded in 1977, conducting Phase I-IV Alzheimer's trials for pharma sponsors and NIH. Provides biomarker, genetic, and PET diagnostics to patients at no cost, with ~10 active trials across the tri-state region.

Ownership category

akta.pro rank

Product category

Clinical Research Services

NAICS

Services for the Elderly and Persons with Disabilities (624120), Services for the Elderly and Persons with Disabilities (62412)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS) (BPAGACAA)

akta.pro secondary industry

Dementia Care Coordination & Care Planning (HSABAEAJ)

Keywords

• Clinical research services
• Alzheimer's clinical trials
• Memory disorder research
• Neurological clinical studies
• Biomarker diagnostic testing

Headquarters

HQ city

Albany

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Clinical Trial Sponsorship: Clinical trials are funded by pharmaceutical companies including Eli Lilly, Eisai, Janssen Pharmaceuticals, Cassava Sciences, and others. Services to patients are provided at no cost; revenue comes from sponsored research agreements.
2. NIH Grants: The center holds a National Institutes of Health (NIH) grant for APOE genetic testing study, providing grant funding for specific research activities.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels6 records

Core offering

The Alzheimer's Disease Research Center of Albany is a private clinical research facility that conducts Phase I-IV Alzheimer's disease and memory disorder clinical trials for pharmaceutical sponsors including Eli Lilly, Eisai, Janssen, and Cassava Sciences. The center provides free diagnostic services (P-tau217 blood testing, APOE genetic testing, cognitive evaluations) and clinical trial participation to patients across the tri-state region and Northeast, with all services offered at no cost to participants and funded through sponsored research agreements and NIH grants.

Product overview

The Alzheimer's Disease Research Center of Albany offers a comprehensive clinical research program centered on Alzheimer's disease and memory disorders. The core offering is its clinical trial program, which includes treatment studies, symptom-focused studies, diagnostic and biomarker studies, prevention/early-detection studies, and observational studies. Supporting diagnostic services include P-tau217 blood testing, APOE genetic testing, and cognitive evaluations. The center provides a Memory Pre-Screening Questionnaire to assess eligibility for research participation. All services are offered at no cost to patients, with studies funded by pharmaceutical companies and conducted under FDA guidelines.

Differentiator

Problem solved

Functional benefit

Products and services

• Alzheimer's Disease Clinical Trials Program Phase I-IV clinical trials evaluating investigational medications, infusions, injections, and other therapies for Alzheimer's disease treatment, symptom management, and prevention, sponsored by pharmaceutical companies including Eli Lilly, Eisai, Janssen Pharmaceuticals, and Cassava Sciences. Provided at no cost to participants.
• P-tau217 Blood Testing

Quantifiable outcome

• 134+ clinical trials completed over 40 years
• +2 more outcomes

Named customers2 records

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Six partnerships are on record, tiered core and minor.

• Global Alzheimer's Platform Foundation (GAP)coreStrategic or Co-development Partner · 1 January 2017Since 2017, the center has been a member of the Global Alzheimer's Platform Foundation, sharing its commitment to accelerating Alzheimer's disease research. Dr. Holub was selected as one of 44 researchers for GAP membership in December 2016. GAP is a public-private partnership launched through collaboration between the New York Academy of Sciences and Global CEO Initiative on Alzheimer's disease.
• Alzheimer's AssociationminorGTM or Marketing PartnerProud partner of the Alzheimer's Association, one of the world's leading voluntary health organizations in Alzheimer's care, support, and research.
• Us Against Alzheimer'sminorGTM or Marketing PartnerPartnered with Us Against Alzheimer's, a national advocacy organization working to stop Alzheimer's as a major health crisis.
• LifePathminorGTM or Marketing PartnerPartnered with LifePath, a community-based organization serving the Capital Region of New York.
• Global Alzheimer's PlatformcoreStrategic or Co-development PartnerGAP is a public-private partnership engaging academic and industry thought leaders within the global Alzheimer's community to accelerate research.
• Congressman Paul TonkominorOthersMet with Dr. Holub and other researchers at the Alzheimer's Association for a round-table discussion on Alzheimer's disease research. Purpose was to give Congressman Tonko a comprehensive view of research activities and allow professionals to collaborate.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• ActivMed Practices & Research: ActivMed is a private clinical research site network with strong CNS and memory-disorder trial experience serving pharma sponsors. Comparable as a multi-therapeutic private research site that runs Alzheimer's and memory trials on a sponsor-funded basis.
• Headlands Research (formerly Compass Research): Headlands Research is a private clinical research site network specializing in CNS and Alzheimer's trials with multiple U.S. locations. Directly comparable as a private, sponsor-funded Phase 1–4 Alzheimer's trial site competing for the same pharma protocols.
• MedTrials Inc. MedTrials is a private clinical research site organization with experience in Alzheimer's and memory-disorder trials. Comparable as a small-to-mid private Phase 1–4 research site serving pharma sponsors in CNS indications.
• Hassman Research Institute (HRI): HRI is a private, New Jersey-based clinical research organization specializing in CNS, neurology, and Alzheimer's trials. Directly comparable as a privately held Phase 1–4 neurology/Alzheimer's research site funded by pharma sponsors.
• Collaborative Neuroscience Network: Collaborative Neuroscience Network is a private CNS-focused clinical trial site network running Phase 1–4 trials for Alzheimer's and other neurological conditions. Comparable as a private, sponsor-funded neurology research site competing for similar protocols.

Others

• Global Alzheimer's Platform Foundation: GAP is a public-private Alzheimer's research consortium of which the Albany center is a member. Comparable as a network and ecosystem partner that channels industry-sponsored protocols to a curated set of high-performing sites, including the subject company.
• Eli Lilly (Lilly Alzheimer’s R&D): Eli Lilly is a major pharmaceutical sponsor of Alzheimer's clinical trials at the Albany center (e.g., for donanemab and related programs). Comparable as a key sponsor partner rather than a competitor, but representative of the customer base the center serves.
• Alzheimer's Association: The Alzheimer's Association is the leading nonprofit funder and advocacy organization in Alzheimer's research and care. Comparable as a community, advocacy, and funding partner supporting Alzheimer's research, including the Albany center's outreach and education efforts.

Broad incumbents

• Banner Alzheimer's Institute: Banner Alzheimer's Institute is a major nonprofit research organization running large-scale Alzheimer's prevention, treatment, and biomarker studies out of Phoenix. Comparable as a leading Alzheimer's research organization but with substantially greater scale and academic affiliation than the Albany center.
• Cleveland Clinic Lou Ruvo Center for Brain Health: The Lou Ruvo Center is a major academic-affiliated Alzheimer's and memory-disorder research and treatment center. Comparable in focus area but operates as part of a large integrated academic health system with significantly more resources and geographic reach.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/alzheimersresearchcenteralbany
• LinkedInlinkedin.com/company/alzheimer-s-disease-research-center

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Alzheimer's Disease Research Center